SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-048961
Filing Date
2021-09-27
Accepted
2021-09-27 08:34:48
Documents
14
Period of Report
2021-09-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20210927.htm   iXBRL 8-K 39028
2 EX-99.1 srpt-ex991_6.htm EX-99.1 27579
3 GRAPHIC gbikrkbxwd3y000001.jpg GRAPHIC 17123
  Complete submission text file 0001564590-21-048961.txt   227809

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srpt-20210927.xsd EX-101.SCH 5729
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20210927_lab.xml EX-101.LAB 19354
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20210927_pre.xml EX-101.PRE 11523
7 EXTRACTED XBRL INSTANCE DOCUMENT srpt-8k_20210927_htm.xml XML 3552
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 211279050
SIC: 2834 Pharmaceutical Preparations